Winway Health Desk
Celgene nabs FDA approval for blockbuster hopeful anemia med Reblozyl
Bristol-Myers Squibb's $74 billion pending pick-up of Celgene has notched a win already with an FDA approval for JAK med Inrebic. Now the consummation...
Healthcare Design Celebrates Women In Design
Healthcare Design, Environments for Aging, Contract, design:retail, and Hospitality Design magazines again joined together to produce Women in Design, a cross-platform program that acknowledges...
Lecture: What You Should Know About CJC-1295 with Ipamorelin, PT-141 also...
TRANSCRIPTGood afternoon, everyone, and thank you for joining us for today’s webinar on some new products being offered by Wells Pharmacy Network. We’re going...
Bruising labor battles put Kaiser Permanente’s reputation on the line
Kaiser Permanente, which just narrowly averted one massive strike, is facing another one Monday.
The ongoing labor battles have undermined the health giant’s once-golden reputation...
Take 5 With Joseph Doherty
In this series, Healthcare Design asks leading healthcare design professionals, firms, and owners to tell us what’s got their attention and share some ideas...
Takeda scores a win for Ninlaro as it aims to pioneer...
Takeda’s ongoing bid to expand the audience for its cancer drug Ninlaro has suffered some setbacks this year, but now the company can claim...
Xealth seeks to consolidate and simplify digital health
One of the ongoing questions at the recently-concluded HLTH conference was: How do we integrate new technologies into well-established workflows? Seattle-based Xealth believes it may...
Sun Pharma fired sales reps after they refused to tout drugs...
Sun Pharma is no stranger to controversy. But after fighting insider trading allegations, Sun is facing a new challenge: In two lawsuits, former salespeople...
Pfizer’s ‘brainstorming’ payment deals as gene therapies advance, exec tells Bloomberg
Gene therapies offer a "world of wonders" for patients, but with some 10,000 of the pricey therapies in development, pharma companies and payers need...
Biogen hit back at whistleblowing sales manager, jury finds, levying $6M...
Former Biogen sales manager Danita Erickson reported a colleague's misconduct and got fired a few months later. Now, she's won $6 million in damages...
